Doctor Ira Jacobs is a fellowship trained surgical oncologist who is currently Pfizer’s oncology biosimilars global medical lead. Prior to Pfizer, Doctor Jacobs worked as a medical director in oncology global development at Amgen. He led clinical development programs in breast, lung, prostate, and bone cancers. Prior to transitioning into industry, Dr. Jacobs was a staff surgical oncologist.
We were excited to have Ira share his expertise on biosimilars on the horizon: opportunities and challenges in the United States at last year’s World Biosimilar Congress USA.
Download his presentation now >
Ira received his BA, MD, and MBA degrees from the George Washington University. He completed a general surgery residency and a surgical oncology fellowship. He is the author of more than 25 publications and has received numerous awards and honors.
You can now download his presentation to find out more about:
- How biologics have made significant contributions to patient care
- The expiration of many biologic patents in the coming years
- The evolution of biologics and the advent of biosimilars from past to present
- Definitions of biosimilars
- Why education of the healthcare community is needed
Download his presentation now >
The World Biosimilar Congress USA is where biopharma developing biosimilars gather to discuss how to access the US market. This year’s event will take place May 19-20 at the Hilton San Diego Resort and Spa.